167 related articles for article (PubMed ID: 12476769)
21. Genetic analysis of wild polioviruses towards the eradication of poliomyelitis from the Western Pacific Region.
Hagiwara A; Yoneyama T; Yoshii K; Yoshida H; Shimizu H; Wada J; Thanh NT; Van Tu P; Miyamura T
Jpn J Infect Dis; 1999 Aug; 52(4):146-9. PubMed ID: 10592893
[TBL] [Abstract][Full Text] [Related]
22. Report of the Australian National Polio Reference Laboratory. 1 January to 31 December 1998.
Kennett M; Brussen KA; Stambos V; Turnbull A; Ibrahim A; Kelly H
Commun Dis Intell; 1999 May; 23(5):124-8. PubMed ID: 10429313
[TBL] [Abstract][Full Text] [Related]
23. Neutralization epitope patterns of poliovirus strains isolated from paralytic cases.
Crainic R; Blondel B; Aubert-Combiescu A; Beytout D; Couillin P; Candrea A; Boué A; Horaud F
Dev Biol Stand; 1984; 57():165-70. PubMed ID: 6084607
[TBL] [Abstract][Full Text] [Related]
24. Molecular epidemiology of wild poliovirus type 1 circulation in West and Central Africa, from 1997 to 1999, using genotyping with a restriction fragment length polymorphism assay.
Gouandjika-Vasilache I; Burns CC; Gumede N; Guillot S; Ménard D; Dosseh A; Akoua-Koffi C; Pallansch MA; Kew OM; Delpeyroux F
Arch Virol; 2008; 153(3):409-16. PubMed ID: 18060590
[TBL] [Abstract][Full Text] [Related]
25. Report of the Australian National Polio Reference Laboratory. 1 July to 31 December 1999.
Kennett M; Stambos V; Turnbull A; Ibrahim A; Kelly H
Commun Dis Intell; 2000 May; 24(5):118-21. PubMed ID: 11085016
[TBL] [Abstract][Full Text] [Related]
26. Annual report of the Australian National Poliovirus Reference Laboratory, 2003.
Brussen KA; Stambos V; Thorley BR
Commun Dis Intell Q Rep; 2004; 28(3):339-44. PubMed ID: 15574057
[TBL] [Abstract][Full Text] [Related]
27. Laboratory surveillance for wild and vaccine-derived polioviruses, January 2004-June 2005.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2005 Sep; 54(38):958-61. PubMed ID: 16195695
[TBL] [Abstract][Full Text] [Related]
28. Isolation and Characterization of Vaccine-Derived Polioviruses, Relevance for the Global Polio Eradication Initiative.
Xu W; Zhang Y
Methods Mol Biol; 2016; 1387():213-26. PubMed ID: 26983736
[TBL] [Abstract][Full Text] [Related]
29. Determination of type 1 poliovirus subtype classes with neutralizing monoclonal antibodies.
Crainic R; Couillin P; Cabau N; Boue A; Horodniceanu F
Dev Biol Stand; 1981; 50():229-34. PubMed ID: 6176486
[TBL] [Abstract][Full Text] [Related]
30. Detecting polio through surveillance for acute flaccid paralysis (AFP).
Deshpande J; Ram M; Durrani S; Wenger J
J Indian Med Assoc; 2005 Dec; 103(12):671-5. PubMed ID: 16821661
[TBL] [Abstract][Full Text] [Related]
31. Three cases of paralytic poliomyelitis associated with type 3 vaccine poliovirus strains in Bulgaria.
Korsun N; Kojouharova M; Vladimirova N; Fiore L; Litvinenko I; Buttinelli G; Fiore S; Voynova-Georgieva V; Mladenova Z; Georgieva D
J Med Virol; 2009 Sep; 81(9):1661-7. PubMed ID: 19626606
[TBL] [Abstract][Full Text] [Related]
32. Circulation of a type 1 recombinant vaccine-derived poliovirus strain in a limited area in Romania.
Combiescu M; Guillot S; Persu A; Baicus A; Pitigoi D; Balanant J; Oprisan G; Crainic R; Delpeyroux F; Aubert-Combiescu A
Arch Virol; 2007; 152(4):727-38. PubMed ID: 17195957
[TBL] [Abstract][Full Text] [Related]
33. The molecular characterization of poliovirus strains by the RT-PCR-RFLP assay and its use in the active surveillance for acute flaccid paralysis cases in Romania between 2001-2006.
Băicuş A; Combiescu M; Persu A; Oprişan G; Aubert-Combiescu A; Delpeyroux F
Roum Arch Microbiol Immunol; 2006; 65(3-4):120-30. PubMed ID: 18389728
[TBL] [Abstract][Full Text] [Related]
34. Lessons from diagnostic investigations of patients with poliomyelitis and their direct contacts for the present surveillance of acute flaccid paralysis.
Herremans T; Koopmans MP; van der Avoort HG; van Loon AM
Clin Infect Dis; 1999 Oct; 29(4):849-54. PubMed ID: 10589902
[TBL] [Abstract][Full Text] [Related]
35. [Acute flaccid paralysis after drug injection: a case report in the pediatric service of the Befelatanana Hospital Center in Antananarivo].
Rasamoelisoa JM; Tovone XG; Rakotovao E; Razafimandimby D; Rakotoarimanana DR; Andriambao D
Arch Inst Pasteur Madagascar; 2000; 66(1-2):58-60. PubMed ID: 12463038
[TBL] [Abstract][Full Text] [Related]
36. Isolation and characterization of circulating type 1 vaccine-derived poliovirus from sewage and stream waters in Hispaniola.
Vinjé J; Gregoricus N; Martin J; Gary HE; Caceres VM; Venczel L; Macadam A; Dobbins JG; Burns C; Wait D; Ko G; Landaverde M; Kew O; Sobsey MD
J Infect Dis; 2004 Apr; 189(7):1168-75. PubMed ID: 15031784
[TBL] [Abstract][Full Text] [Related]
37. Quantitation of D antigen content in inactivated poliovirus vaccine derived from wild-type or sabin strains.
Sawyer LA; McInnis J; Albrecht P
Biologicals; 1993 Jun; 21(2):169-77. PubMed ID: 8297601
[TBL] [Abstract][Full Text] [Related]
38. Laboratory surveillance for wild and vaccine-derived polioviruses--worldwide, January 2007-June 2008.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2008 Sep; 57(35):967-70. PubMed ID: 18772852
[TBL] [Abstract][Full Text] [Related]
39. A direct ELISA technique to detect antibodies against polioviruses.
Murthy N; Nair KM; Bhaskaram P
Indian J Biochem Biophys; 1995 Oct; 32(5):249-53. PubMed ID: 8713745
[TBL] [Abstract][Full Text] [Related]
40. Environmental surveillance of poliovirus in Italy: pilot study.
Patti AM; Santi AL; Fiore L; Vellucci L; De Stefano D; Bellelli E; Barbuti S; Fara GM
Ann Ig; 2003; 15(2):97-105. PubMed ID: 12838824
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
